Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0349USD
−24.73 MUSD
87.29 KUSD
553.54 M
About BRII BIOSCIENCES L
Sector
CEO
Zhi Hong
Website
Headquarters
Haidian
Employees (FY)
128
Founded
2017
FIGI
BBG0147C6QL9
Brii Biosciences Ltd. engages in advancing therapies for significant infectious diseases and other illnesses which have significant public health burdens. The firm also focuses on developing therapies for infectious diseases and central nervous system diseases. The company was founded by Zhi Hong on December 8, 2017, and is headquartered in Beijing, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BRIBF is 0.1832 USD — it has increased by 1.22% in the past 24 hours. Watch BRII BIOSCIENCE LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange BRII BIOSCIENCE LTD stocks are traded under the ticker BRIBF.
We've gathered analysts' opinions on BRII BIOSCIENCE LTD future price: according to them, BRIBF price has a max estimate of 0.76 USD and a min estimate of 0.76 USD. Watch BRIBF chart and read a more detailed BRII BIOSCIENCE LTD stock forecast: see what analysts think of BRII BIOSCIENCE LTD and suggest that you do with its stocks.
BRIBF reached its all-time high on Jan 21, 2022 with the price of 2.7500 USD, and its all-time low was 0.0028 USD and was reached on Sep 2, 2022. View more price dynamics on BRIBF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BRIBF stock is 1.20% volatile and has beta coefficient of 1.58. Track BRII BIOSCIENCE LTD stock price on the chart and check out the list of the most volatile stocks — is BRII BIOSCIENCE LTD there?
Today BRII BIOSCIENCE LTD has the market capitalization of 109.19 M, it has decreased by 5.83% over the last week.
Yes, you can track BRII BIOSCIENCE LTD financials in yearly and quarterly reports right on TradingView.
BRII BIOSCIENCE LTD is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
BRIBF earnings for the last quarter are 0.00 USD per share, whereas the estimation was −0.15 USD resulting in a 101.90% surprise. The estimated earnings for the next quarter are −0.05 USD per share. See more details about BRII BIOSCIENCE LTD earnings.
BRIBF net income for the last quarter is 2.09 M USD, while the quarter before that showed −27.40 M USD of net income which accounts for 107.62% change. Track more BRII BIOSCIENCE LTD financial stats to get the full picture.
No, BRIBF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 2, 2024, the company has 128.00 employees. See our rating of the largest employees — is BRII BIOSCIENCE LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BRII BIOSCIENCE LTD EBITDA is −82.75 M USD, and current EBITDA margin is −94.71 K%. See more stats in BRII BIOSCIENCE LTD financial statements.
Like other stocks, BRIBF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BRII BIOSCIENCE LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BRII BIOSCIENCE LTD technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BRII BIOSCIENCE LTD stock shows the sell signal. See more of BRII BIOSCIENCE LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.